Li Ding
- Cancer Research top 0.05%
- Cancer Genomics and Diagnostics 54
- Cancer-related molecular mechanisms research 23
- Hematology top 0.5%
- Acute Myeloid Leukemia Research 12
- Oncology top 0.5%
- Molecular Biology top 0.5%
- Genomics and Phylogenetic Studies 17
- RNA modifications and cancer 16
- Epigenetics and DNA Methylation 15
- Single-cell and spatial transcriptomics 12
- Genetics top 0.2%
-
- Ferroptosis and cancer prognosis 11
- Co-authors
- Richard K. WilsonMichael D. McLellanElaine R. MardisQunyuan ZhangChristopher A. MillerDaniel C. KoboldtDavid E. LarsonMichael C. Wendl
- Cited by
- Cancer ResearchHematologyOncology
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Li Ding
316 papers receiving 17.9k citations
Hit Papers
Peers
Comparison fields: 5 of 198
- Cancer Research 6.3k
- Hematology 1.7k
- Oncology 3.9k
- Molecular Biology 9.7k
- Genetics 3.2k
Countries citing papers authored by Li Ding
This map shows the geographic impact of Li Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Ding more than expected).
Fields of papers citing papers by Li Ding
This network shows the impact of papers produced by Li Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Ding. The network helps show where Li Ding may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Li Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 6 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 14 | |
| 12 | 2023 | 2 | |
| 13 | 2023 | 30 | |
| 14 | 2022 | 29 | |
| 15 | Nrf2 Inhibits the Progression of Parkinson’s Disease by Upregulating AABR07032261.5 to Repress Pyroptosis | 2022 | 21 |
| 16 | 2020 | 55 | |
| 17 | 2020 | 19 | |
| 18 | Apolipoprotein C1 (APOC1) promotes tumor progression via MAPK signaling pathways in colorectal cancer | 2019 | 5 |
| 19 | 2019 | 27 | |
| 20 | 2014 | 3 |
About Li Ding
Li Ding is a scholar working on Cancer Research, Hematology, Oncology, Molecular Biology and Orthodontics, having authored 337 papers that have together received 18.1k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (54 papers), Cancer-related molecular mechanisms research (23 papers), Genomics and Phylogenetic Studies (17 papers), RNA modifications and cancer (16 papers), Epigenetics and DNA Methylation (15 papers), Acute Myeloid Leukemia Research (12 papers), Single-cell and spatial transcriptomics (12 papers) and Ferroptosis and cancer prognosis (11 papers). The work is most often cited by research in Cancer Research (6.3k citations), Hematology (1.7k citations), Oncology (3.9k citations), Molecular Biology (9.7k citations) and Genetics (3.2k citations). Li Ding has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Richard K. Wilson, Michael D. McLellan, Elaine R. Mardis, Qunyuan Zhang, Christopher A. Miller, Daniel C. Koboldt, David E. Larson, Michael C. Wendl, Timothy J. Ley and Dong Shen. Their work appears in journals such as Blood, Cancer Research, Bioinformatics, Genome Research and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.